RecruitingNCT06577805

The Outcomes of Living Donor Robotic Assisted Kidney Transplantation

A Retrospective Cohort Study of Prospectively Collect the Outcomes of Recipients After Robot-assisted Kidney Transplantation

Sponsor

West China Hospital

Enrollment

400 participants

Start Date

Jul 1, 2020

Study Type

OBSERVATIONAL

Conditions

Kidney Transplant; Complications Renal Failure Chronic

Summary

The technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This advancement is particularly noteworthy as it extends its suitability to transplant patients with obesity. It will be important to explore the results of robot-assisted kidney transplantation as compared with open surgery or within cohorts.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is reviewing outcomes in people who received a kidney transplant from a living donor using robotic-assisted surgery, to evaluate how safe and effective this newer surgical technique is compared to traditional approaches. **You may be eligible if...** - You received a kidney from a living donor - You are on the standard three-drug immune-suppressing regimen after transplant **You may NOT be eligible if...** - You had an active infection at the time of transplant - You received more than one organ (multi-organ transplant) - You or your donor had a history of cancer - You are HIV-positive Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.